Merck KGaA Signs Korea Science Research Pact
Provided by
Dow Jones
By Ian Walker
Merck KGaA has signed an agreement with Korea Advanced Institute of Science and Technology enabling its researchers to use Merck's chemistry and biology portfolios.
Under the non-binding memorandum of understanding announced late Wednesday, the German life-sciences and electronics company will also offer development opportunities for lab researchers.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
May 30, 2024 01:19 ET (05:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations